User profiles for "author:Tristan J Barber"
 | Tristan J BarberRoyal Free London NHS Foundation Trust Verified email at nhs.net Cited by 1788 |
Unified European support framework to sustain the HIV cascade of care for people living with HIV including in displaced populations of war-struck Ukraine
M Vasylyev, A Skrzat-Klapaczyńska, JI Bernardino… - The Lancet …, 2022 - thelancet.com
Ukraine is one of the countries in Europe most affected by HIV. The escalation of open war
on the European continent has affected HIV care in Ukraine in an unprecedented way …
on the European continent has affected HIV care in Ukraine in an unprecedented way …
Changes in inflammatory and atherogenesis biomarkers with the 2-drug regimen dolutegravir plus lamivudine in antiretroviral therapy–experienced, virologically …
Background The 2-drug regimen dolutegravir plus lamivudine has demonstrated long-term
noninferior efficacy vs 3-/4-drug regimens (3/4DRs) in phase 3 trials. This systematic …
noninferior efficacy vs 3-/4-drug regimens (3/4DRs) in phase 3 trials. This systematic …
Frailty in people living with HIV: an update
Frailty in people living with HIV: an update : Current Opinion in Infectious Diseases Frailty in
people living with HIV: an update : Current Opinion in Infectious Diseases Log in or Register …
people living with HIV: an update : Current Opinion in Infectious Diseases Log in or Register …
[PDF][PDF] Attenuated humoral responses in HIV after SARS-CoV-2 vaccination linked to B cell defects and altered immune profiles
E Touizer, A Alrubayyi, R Ford, N Hussain, PP Gerber… - Iscience, 2023 - cell.com
We assessed a cohort of people living with human immunodeficiency virus (PLWH)(n= 110)
and HIV negative controls (n= 64) after 1, 2 or 3 SARS-CoV-2 vaccine doses. At all …
and HIV negative controls (n= 64) after 1, 2 or 3 SARS-CoV-2 vaccine doses. At all …
Real world use of dolutegravir two drug regimens
C Bowman, A Ambrose, T Kanitkar, K Flores, P Simoes… - AIDS, 2023 - journals.lww.com
Background: Since 2015, we prescribed dolutegravir (DTG)-based two drug regimens (DTG-
2DR) for 620 people [total cohort 3133 (19.8%)]. Method: Clinic database search 1 January …
2DR) for 620 people [total cohort 3133 (19.8%)]. Method: Clinic database search 1 January …
[HTML][HTML] How do geriatricians feel about managing older people living with HIV? A scoping review
HT Jones, TJ Barber - European geriatric medicine, 2022 - Springer
Purpose The proportion of people living with HIV being older adults is increasing and due to
high rates of multimorbidity and frailty within this group geriatricians are well placed to …
high rates of multimorbidity and frailty within this group geriatricians are well placed to …
Outcomes in the first year after initiation of first-line HAART among heterosexual men and women in the UK CHIC Study
UK CHIC Study Steering Committee… - Antiviral …, 2011 - journals.sagepub.com
Background We analysed the influence of gender on use and outcomes of first-line HAART
in a UK cohort. Methods Analyses included heterosexuals starting HAART from 1998-2007 …
in a UK cohort. Methods Analyses included heterosexuals starting HAART from 1998-2007 …
Frequency and patterns of protease gene resistance mutations in HIV-infected patients treated with lopinavir/ritonavir as their first protease inhibitor
TJ Barber, L Harrison, D Asboe… - Journal of …, 2012 - academic.oup.com
Background Selection of protease mutations on antiretroviral therapy (ART) including a
ritonavir-boosted protease inhibitor (PI) has been reported infrequently. Scarce data exist …
ritonavir-boosted protease inhibitor (PI) has been reported infrequently. Scarce data exist …
[HTML][HTML] Natural killer cell responses during SARS-CoV-2 infection and vaccination in people living with HIV-1
Natural killer (NK) cell subsets with adaptive properties are emerging as regulators of
vaccine-induced T and B cell responses and are specialized towards antibody-dependent …
vaccine-induced T and B cell responses and are specialized towards antibody-dependent …
What problems associated with ageing are seen in a specialist service for older people living with HIV?
HT Jones, A Samji, N Cope, J Williams… - HIV …, 2022 - Wiley Online Library
Objectives By 2030 the majority of the people living with HIV in the United Kingdom will be
over the age of 50. HIV services globally must adapt to manage people living with HIV as …
over the age of 50. HIV services globally must adapt to manage people living with HIV as …